Patients with non-alcoholic fatty liver disease may benefit from increased dietary niacin intake

Whether higher dietary niacin intake lowers the risk of all-cause, heart and cerebrovascular disease(s).

LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab – Biotech Investments

EQS-News: Lindis Biotech GmbH / Key word(s): Agreement LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab 19.11.2024 / 10:07 CET/CEST The

November 20, 2024

Hutchmed’s licensing deal, worth up to $227M; Tyra’s $200 PIPE

Plus, news about Anbogen Therapeutics and Vera Therapeutics: Hutchmed inks deal of up to $227.5M: The company is licensing two drugs to Immagene Biopharmaceuticals: IMG-007,

February 3, 2024

Oregon suspends a portion of its drug transparency law found to be unconstitutional

In a victory for the pharmaceutical industry, Oregon officials have suspended a portion of a contentious state law designed to bring more transparency to prescription

February 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.